Table 6 Frequencies of depression and anxiety AEs, VigiAccess data.

From: Common osteoporosis drug associated with increased rates of depression and anxiety

 

Alendronate

Zoledronate

Risedronate

Ibandronate

Denosumab

Teriparatide

Depression (%)

3180/51,022 (6.23)

1101/54,018 (2.04)

409/13,507 (3.03)

889/25,575 (3.48)

676/129,045 (0.52)

2128/140,664 (1.5)

Anxiety (%)

2477/51,022 (4.85)

1036/54,018 (1.92)

304/13,507 (2.25)

648/25,575 (2.53)

480/129,045 (0.37)

2247/140,664 (1.60)